scispace - formally typeset
G

Gloria S. Pryhuber

Researcher at University of Rochester

Publications -  147
Citations -  5503

Gloria S. Pryhuber is an academic researcher from University of Rochester. The author has contributed to research in topics: Bronchopulmonary dysplasia & Lung. The author has an hindex of 39, co-authored 120 publications receiving 4489 citations. Previous affiliations of Gloria S. Pryhuber include University of Cincinnati Academic Health Center & Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia.

TL;DR: It is concluded that infants dying with BPD have abnormal alveolar microvessels and that disordered expression of angiogenic growth factors and their receptors may contribute to these abnormalities.
Journal ArticleDOI

The human body at cellular resolution: the NIH Human Biomolecular Atlas Program

Michael Snyder, +133 more
- 09 Oct 2019 - 
TL;DR: The NIH Common Fund Human Biomolecular Atlas Program (HuBMAP) intends to develop a widely accessible framework for comprehensively mapping the human body at single-cell resolution by supporting technology development, data acquisition, and detailed spatial mapping.
Journal ArticleDOI

Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons

TL;DR: The data suggest that CLD impairs lung microvascular development and that a possible mechanism is disruption of VEGF and Flt-1 expression.
Journal ArticleDOI

Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

TL;DR: This paper reviews present pharmacotherapy for ALI/ARDS in the context of biological and biochemical drug activities and concludes that there is a significant need for more effective medicinal chemical agents for use in these severe and lethal lung injury syndromes.
Journal ArticleDOI

Proteomic Analysis of Single Mammalian Cells Enabled by Microfluidic Nanodroplet Sample Preparation and Ultrasensitive NanoLC‐MS

TL;DR: It is demonstrated that the single-cell proteomics platform can be used to differentiate cell types from enzyme-dissociated human lung primary cells and identify specific protein markers for epithelial and mesenchymal cells.